UNSPSC 51181615: Dibromotyrosine

This classification denotes a tyrosine analog and non-essential amino acid with the molecular formula C9H9Br2NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QD49LEP46E, chemically known as 3,5-dibromotyrosine but generally known as dibromotyrosine, which bears US NIH Compound Identifier 10833. European Medicines Agency schedules Dibromotyrosine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13561MIG.

World Health Organization schedules dibromotyrosine in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, DIBROMOTYROSINE remains the US FDA Preferred Term for this commodity. SMILES: BRC1CC(CC(N)C(=O)O)CC(BR)C1O.

UNSPSC 51181615 Dibromotyrosine, a Commodity code, describes a specialized biochemical reagent purchased by state and local governments for laboratory and research applications. State and local procurement activity under this code is minimal. The source provides no recent state or local contract opportunities soliciting dibromotyrosine or related biochemical reagents. Without posted RFP, RFQ, IFB, or ITB activity in the recent-opportunities block, the code shows no actionable current market signal for business development purposes under state and local procurement channels at this time.

No representative opportunities, issuing bodies, or geographic concentration can be characterized from available recent activity.